Making the Difference in Precision Medicine

Pathologists and Hospital Leaders Leverage New Technologies in Prognostic and Predictive Patient Care

  • Event Date:
  • Event Time: 11 a.m. Central

As the era of precision medicine unfolds, pathologists and clinical laboratories have become increasingly valuable in ensuring the quality, safety and value of the patient’s medical journey.

Pathology not only holds the key to the accuracy and speed of diagnosis but is also gaining more recognition from clinicians and patients through its role in providing valuable prognostic and predictive information to guide patient care decisions.

Marilyn M. Bui, MD, PhD, FCAP, and Robert J. Keenan, MD, MMM, will illustrate some best-practice examples from their experiences at Moffitt Cancer Center on how pathologists and clinical laboratories can partner with their health care leaders in improving cancer care.

The collaborative advantage of close partnerships among pathologists, hospital administrators and other clinicians is key to effective patient-centered precision medicine. By leveraging and developing emerging technologies like digital pathology and artificial intelligence, pathologists will more fully be able to diagnose disease and work with clinicians in more accurately guiding treatment.

What You Will Learn:

  • How to best partner your medical laboratory with clinical partners to guide diagnosis and treatment on the patient’s journey.
  • How pathologists and the medical laboratory help ensure quality and cost-effective patient care.
  • How to leverage and plan for current applications and future implications of digital pathology and artificial intelligence in cancer care


College of American Pathologists logo

« View All Events

Thought Leaders

Robert J. Keenan, MD, MMM
Vice President of Quality and Chief Medical Officer
Moffitt Cancer Center
Robert J. Keenan, MD, MMM image

Robert J. Keenan, MD, M.M.M. is vice president of Quality and chief medical officer for Moffitt Cancer Center. In this role he provides senior leadership to Clinical Service Chiefs, Hospital and Clinic Medical Directors, and Medical Staff Affairs. Dr. Keenan also oversees the quality of clinical services and develops clinical performance improvement efforts to maximize the value of care for patients.

A native of Ontario, Canada, Keenan’s childhood fostered passions for wildlife ecology and medicine. He received his medical degree from the University of Alberta and subsequently completed a residency in general surgery and fellowship in thoracic surgery at hospitals of the University of Toronto School of Medicine in Toronto.

Between his residency and fellowship, Dr. Keenan spent two years conducting  lung transplantation research at the University of Pittsburgh, where became a faculty member upon completion of fellowship in 1992. During eight years at the University of Pittsburgh, Dr. Keenan held the titles of director of Thoracic Surgery, vice-chair of the Division of Cardiothoracic Surgery and director of the Lung Transplant and Lung Volume Reduction programs.

In 2000, Dr. Keenan joined the West Penn Allegheny Health System (now Allegheny Health Network) as system director of Thoracic Surgery and Chief Quality Officer for two of the system’s major hospitals. In 2015, he was recruited to join Moffitt as the Chief Medical Officer and vice president of Quality.

Dr. Keenan is a senior member in the Department of Thoracic Oncology and a professor of Oncologic Sciences at the University of South Florida. He is a fellow of the American College of Surgeons and of the Royal College of Surgeons of Canada. In clinical research activities, Dr. Keenan is a principal investigator for the National Emphysema Treatment Trial, a site principal investigator for numerous thoracic oncology cooperative group trials through ACOSOG, CALGB and ECOG and a national co-investigator for a randomized trial for early stage lung cancers.

He is the author or co-author of over 230 scientific articles and book chapters. In the area of quality, Dr. Keenan has been an examiner for the Malcolm Baldrige National Quality Award and holds a Healthcare Lean Certificate from the University of Michigan.


Marilyn Bui, MD, PhD, FCAP
Scientific Director of Analytic Microscopy Core
Moffitt Cancer Center
Marilyn Bui, MD, PhD, FCAP image

Marilyn M. Bui, MD, PhD is a Senior Member in the Department of Pathology at Moffitt Cancer Center. Dr. Bui serves as the Scientific Director of Analytic Microscopy Core, the Section Head of Bone and Soft Tissue Pathology, and the President of Medical Staff. She is also a Professor and Director of the Cytopathology Fellowship at the University of South Florida (USF) Morsani College of Medicine. Providing the best possible patient care is the number one mission for Dr. Bui. She also leverages research, education, advocacy and service for better patient care. She has published over 180 peer-reviewed articles, 20 book chapters and 3 books. She values the service to professional societies as an important mechanism to influence policies and standards to improve the quality of patience care in a broader sense. Dr. Bui is the President of the Digital Pathology Association. She chairs the Expert Panel of the Quantitative Image Analysis (QIA) project and published a guideline to improve the accuracy, precision and reproducibility of breast cancer HER2 IHC QIA interpretation and reporting of the College of American Pathologists (CAP) as the lead author. She chairs the CAP Publications Committee and serves as the Vice Chair of the CAP Digital Pathology Committee. Dr. Bui has earned a number of awards in cancer research, education and service. She is the awardee of the College of American Pathologists 2019 Distinguished Patient Care award. Dr. Bui advocates the important role of pathologists in the improvement of quality, safety and value of patient care while being a loyal and supportive colleague to all the team members.  

On Demand Button